The goal of this project is the development of stable and representative microbial communities, which can serve as models for healthy or disturbed intestinal flora, and with which the in vitro SHIME gastro-intestinal simulation platform may be inoculated. This innovative technology, the expansion of the in vitro simulation platform Prodigest will allow the pharmaceutical and therapeutic market.